PHARMA

PHARMA
Astrazenica — Precision Medicine HCP Educational Website
Period: 2021-2022
Overview: Transitioned creative teams from Adobe XD to Figma.
Challenge: Modernize workflows across teams without disrupting delivery.
My Role: ACD, Pharma, Website. Served as Figma design system educator and UX & UI co-architect.
Creative Approach: Implemented component-based design and shared libraries.
Execution: Built templates, systems, and led training sessions.
Impact: Accelerated collaboration and reduced revision cycles.
Reflection: A transformational upgrade for team process and output.
“Precision medicine is an innovative approach for tailoring disease treatment and prevention. It makes it possible for doctors and researchers to more accurately predict which treatments are more likely to work for a patient, taking into account individual genetic and molecular make-up, environment, and lifestyle.
By unravelling the complex underlying biology of many diseases, and pioneering and applying advanced technologies, we are leading the way in the application of precision medicine. Our work, and our collaborations with partners across industry, biotech and academia, are driving for better treatments for patients as well as a more sustainable future for healthcare systems.”
I worked in close partnership with our Creative Directors and the client team to determine the most effective way to articulate complex, HCP-focused messaging within a scalable digital ecosystem. The challenge was significant: we needed to translate a dense volume of medical information into a site experience that could flex based on the user’s needs, clinical literacy, and navigation behaviors — all while maintaining clarity, compliance, and a sense of intuitive flow. This required not only strong conceptual thinking, but a deep understanding of user pathways, content hierarchy, and how clinicians absorb information in a digital environment.
From the earliest planning stages through final production, I managed key stakeholders and shepherded the work from concept to completion. This meant coordinating across cross-functional internal teams and external vendors to ensure alignment at every stage. I served as a central creative anchor throughout the process, making certain that timelines, deliverables, and expectations remained consistent and achievable. In pharma, the volume of oversight — medical, legal, regulatory, client, internal — can be immense, and maintaining cohesion through that complexity was a critical part of my leadership.
As part of my broader role, I provided ongoing leadership and professional development for the creative staff, guiding designers, writers, and digital artists in elevating their craft while simultaneously preparing them for evolving workflows and technologies. A significant portion of this involved actively training the team on Figma — from component building to collaborative workflows — and helping them transition smoothly from Adobe XD. Ensuring the team was empowered and capable of operating confidently in new platforms wasn’t just a workflow upgrade; it directly improved our efficiency, collaboration, and overall quality of output.
I maintained oversight of the brand identity, functional logic, and messaging consistency across all touchpoints. Whether evaluating UI components, refining content modules, or aligning visual behaviors across desktop and mobile experiences, I ensured that every element reinforced the brand’s strategic architecture and communicated with precision. Consistency is especially critical in HCP-facing materials, where even small deviations in tone or structure can create misunderstandings or dilute the brand’s credibility.
Throughout the project, I also conducted rigorous reviews of digital creative concepts, evaluating copy, UX thinking, and visual design at predetermined checkpoints before work moved to account management or client-facing stages. These evaluations provided space for early adjustments, refinements, and strategic tightening — ensuring that by the time work reached the client, it was not only polished, but grounded in insight, clarity, and purpose.
Overall, my contribution combined creative leadership, operational oversight, and a strong understanding of regulated content — resulting in a digital experience that delivered high-value information with precision, accessibility, and a cohesive brand voice.
ETHANGABRIELHUNT.NYC > PROPERTY OF ETHAN GABRIEL HUNT > 2026©